Data_Sheet_1_The Preventive Effects of Fermented and Germinated Foxtail Millet Whole Grain on Kidney Damage in a Diabetic Mouse Model.ZIP by Xia Liu (117318)

Beluga-Halibut-Si-Data from Temporal shifts in intraguild predation pressure between beluga whales and Greenland halibut in a changing Arctic. by David J. Yurkowskil (4556449)

BMAL1 and PER1 protein and transcript levels are reduced by thyroxine treatment. by Jonathan A. Hardman (714625)

“…(b,d) PER1 protein was significantly decreased by T4 at 6, 12,18 and 24 hours. BMAL1 protein levels were also decreased significantly by T4 at time points 6,12 and 18 hours showing a tendency to decrease at 0 and 24 hours. …”

Table_1_Dose-response relationship between iTBS and prefrontal activation during executive functioning: A fNIRS study.docx by Bella B. B. Zhang (14280854)

“…All participants received a single session iTBS over the left DLPFC at intensities of 50, 70, or 100% of their individual resting motor threshold (RMT), each on separate visits. …”

Image_1_Changes in fecal microbiota composition and the cytokine expression profile in school-aged children with depression: A case-control study.jpeg by Zongxin Ling (155251)

“…We also identified the presence of a complex inflammatory condition in children with depression, characterized by increased levels of pro-inflammatory cytokines such as IL-17 and decreased levels of anti-inflammatory cytokines such as IFN-γ. …”

Table_1_Changes in fecal microbiota composition and the cytokine expression profile in school-aged children with depression: A case-control study.docx by Zongxin Ling (155251)

“…We also identified the presence of a complex inflammatory condition in children with depression, characterized by increased levels of pro-inflammatory cytokines such as IL-17 and decreased levels of anti-inflammatory cytokines such as IFN-γ. …”

Data_Sheet_1_Nuclear Import of a Secreted “Candidatus Liberibacter asiaticus” Protein is Temperature Dependent and Contributes to Pathogenicity in Nicotiana benthamiana.doc by Xuelu Liu (4678894)

Supplementary Material for: Epidemiological and Treatment Trends for Acute Ischemic Stroke Preceding and during the COVID-19 Pandemic by Rodrigues A. (11465470)

“…The database contains the longitudinal healthcare claims of approximately 77 million patients covered by a major insurance provider between 2003 and June 30, 2020 across all 50 states. …”

Supplementary Material for: Waning of SARS-CoV-2 Vaccine-Induced Immune Response over 6 Months in Peritoneal Dialysis Patients and the Role of a Booster Dose in Maintaining Seropos... by Murt A. (9984845)

“…The initial seropositivity rate was 90.9% with inactivated vaccine and 100% with mRNA vaccine. Seropositivity decreased to 44.4% after 6 months, and a booster dose helped in maintaining the 100% of seropositivity (<i>p</i> = 0.005). …”

Notch Stimulates Both Self-Renewal and Lineage Plasticity in a Subset of Murine CD9^High Committed Megakaryocytic Progenitors by Michèle Weiss-Gayet (505300)

Image_2_Natural Killer Cell Degranulation Defect: A Cause for Impaired NK-Cell Cytotoxicity and Hyperinflammation in Fanconi Anemia Patients.TIF by Snehal Shabrish (6494090)

Image1_A Novel Loss-of-Function Mutation in the NPRL3 Gene Identified in Chinese Familial Focal Epilepsy with Variable Foci.JPEG by Youzhi Li (5737322)

Image_3_Natural Killer Cell Degranulation Defect: A Cause for Impaired NK-Cell Cytotoxicity and Hyperinflammation in Fanconi Anemia Patients.tif by Snehal Shabrish (6494090)

Image_1_Natural Killer Cell Degranulation Defect: A Cause for Impaired NK-Cell Cytotoxicity and Hyperinflammation in Fanconi Anemia Patients.TIF by Snehal Shabrish (6494090)

Predicted change in current financial strain between M2 (2004–05) and M3 (2013–14) by changes in assets. by Dana A. Glei (1939324)

“…The difference (M3—M2) in log assets is equivalent to the log of the ratio of assets at M3 relative to M2. Thus, a 0.7 decrease in log assets represents a loss of 50% (24% of the observed sample exhibited a loss of that magnitude or greater), whereas a 0.7 increase corresponds with an approximate doubling of assets (28% of the sample reported a gain of that magnitude or greater). …”

Comparative analysis of different doses of coherent light (laser) and non-coherent light (light-emitting diode) on cellular necrosis and apoptosis: a study in vitro by Vanessa dos Santos Silva (6147899)

“…At t24, the LED 40J/cm2 (80±20%, p<0.05) group also showed more necrosis than the control and lower dose groups (laser 10, 20, and 30J/cm2 percentage of 6±4, 10±3 and 7±3%, p<0.05; LED 10 and 20J/cm2 percentage of 3±1 and 17±10%, p<0.05). A decrease in apoptotic cells was observed in the laser group with doses of 10, 40, and 50J/cm2 (6±4, 3±1 and 1±1% respectively, not significant), as well as in the LED 40J/cm2 (2±2%, not significant) group versus control. …”

Molecular mass of peak samples of HWHF by LC-MS analysis. by Prawej Ansari (12191266)

Presentation1_A Key Silencing Histone Mark on Chromatin Is Lost When Colorectal Adenocarcinoma Cells Are Depleted of Methionine by Methionine γ-Lyase.pdf by Samanta Raboni (475265)

“…Although the levels of total histone methylation were not altered, a loss of the silencing histone mark H3K9me2 was observed, as well as a decrease in H4K20me3. …”

Supplementary Material for: Preliminary efficacy, tolerability, and safety analysis of Darolutamide for metastatic castration‑resistant prostate cancer: a single-center, open-label... by Yu J. (3610580)

“…Results: 37 patients with mCRPC were enrolled. The median time to PSA50 in the Darolutamide group was 1.5 months (95%CI 0.2619- 0.9545), significantly lower than that in the placebo group (3.0 months [95%CI 1.048- 3.818], p= 0.0259); The median time to PSA90 in the experimental group was 4 months (95%CI 0.3094- 1.437), 2 months shorter than that in the placebo group (6.0 months [95%CI 0.6961- 3.232]).With the median follow-up of 6 months, , the median decrease in serum PSA was -81.8% (range -60.4 to -99.9%) in the Darolutamide group and -69.4% (range -50.3 to -89.6%) in the placebo group. …”

Supplementary Material for: The current status of tumor markers as biomarkers in the era of immunotherapy for hepatocellular carcinoma: alpha-fetoprotein alone is not sufficient by Hiraoka A. (4273894)

“…Positive rates for AFP (67.8%, 62.1%, 50.8%, respectively) and DCP (84.1%, 80.5%, 72.7%, respectively) were decreased (each P<0.001), while the AFP-L3 rate did not show a significant change (54.4%, 57.7%, 51.9%, respectively P=0.390). …”